Nachrichten zur Vertex Pharmaceuticals Inc. Aktie

The Zacks Analyst Blog Highlights: NIKE, Amgen, Morgan Stanley, Vertex Pharma and Moderna

The Zacks Analyst Blog Highlights: NIKE, Amgen, Morgan Stanley, Vertex Pharma and Moderna...…

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $241.31, moving +1.57% from the previous trading session....…

Vertex Pharmaceuticals: A Play On Market Overreaction

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why the Earnings Surprise Streak Could Continue for Vertex (VRTX)

Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Vertex Pharmaceuticals (VRTX) Stock Moves -0.25%: What You Should Know

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $225.55, marking a -0.25% move from the previous day....…

Vertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vertex Pharma projects a larger long-term opportunity in CF

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

Vertex Pharmaceuticals (VRTX) closed at $237 in the latest trading session, marking a +1.76% move from the prior day....…

5 Disruptive Biotech Stocks With Solid Long-Term Potential

Here we discuss five biotech stocks - EDIT, VRTX, NTLA, CBAY, MRNS - that could prove to be great investments…

Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know

Vertex Pharmaceuticals (VRTX) closed at $234.46 in the latest trading session, marking a -0.59% move from the prior day....…

Vertex (VRTX) Inks Deal with Skyhawk for Serious Diseases

Vertex (VRTX) signs a licensing agreement with privately held company Skyhawk Therapeutics to discover novel small molecules that modulate RNA…

Vertex Pharmaceuticals Enters New Partnership With RNA Expert Skyhawk Therapeutics

The large biotech firm is just the latest deep-pocketed player to ink a heavily backloaded deal with the RNA-splicing specialist....…

Vertex Pharma, Skyhawk Therapeutic in licensing pact for RNA splicing modulating therapies

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vertex Pharmaceuticals (VRTX) Stock Moves -0.08%: What You Should Know

Vertex Pharmaceuticals (VRTX) closed at $236.72 in the latest trading session, marking a -0.08% move from the prior day....…

Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $224.17, moving +0.06% from the previous trading session....…

Is Vertex Pharmaceuticals Stock a Buy?

This high-flying biotech is trading on the cheap....…

Vertex (VRTX) Symkevi/Kalydeco Label Expansion Gets EU Nod

Vertex (VRTX) gets European approval for label expansion of Symkevi and Kalydeco combination pill in cystic fibrosis patients aged six…

Vertex Pharmaceuticals Board approves $500M stock buyback program

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

VERTEX PHARMACEUTICALS INC / MA: 8-K Report

8-K...…

Vertex Pharmaceuticals Incorporated (VRTX) Presents at Jefferies London Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Here are the stocks seeing the most insider buying this week

CNBC's Brian Sullivan highlights the stocks seeing the most insider buying this week, on Worldwide Exchange, including names like Hanes…

Insiderhandel: EVP, Chief Adm, Leg & BD Off verkauft Aktien von Vertex Pharmaceuticals im Wert von 507.329 $

Parini, Michael - Vorstand - Tag der Transaktion: 2020-11-04...…

BIIB Faces FDA Panel Tomorrow, CRSP Climbs On Hemoglobinopathies Trial Data, SAVA On Watch

Todays Daily Dose brings you news about FDAs briefing information related to Biogens Alzheimers drug candidate ahead of the panel…

CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Plenary Presentation at the 62nd American Society of Hematology (ASH) Meeting and Exposition

ZUG, Switzerland and CAMBRIDGE, Mass. and BOSTON, Nov. 04, 2020 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) and…

3 Reasons to Buy Vertex Pharmaceuticals and 1 Reason Not To

What will the drugmaker do once it has the cystic fibrosis market cornered?...…

VERTEX PHARMACEUTICALS INC / MA: 10-Q Report

10-Q...…

Vertex Pharmaceuticals Incorporated 2020 Q3 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vertex (VRTX) Beats on Q3 Earnings & Sales, Ups Sales View

Vertex (VRTX) beats estimates for both earnings and sales and raises revenue guidance for 2020....…

Vertex Pharmaceuticals Inc (VRTX) Q3 2020 Earnings Call Transcript

VRTX earnings call for the period ending September 30, 2020....…

Vertex Pharmaceuticals, Inc. (VRTX) CEO Reshma Kewalramani on Q3 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Recap: Vertex Pharmaceuticals Q3 Earnings

Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) decreased 1.4% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased…

Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals

These two rare-disease drug developers are experts at penetrating their markets....…

Biotech Stock Roundup: BIIB Posts Q3 Results, VRTX Stops Study & Other Updates

The biotech sector was in focus as Biogens (BIIB) Q3 results disappoint, Vertex (VRTX) stops study and Regenerons (REGN) Ebola…

Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity

Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity...…

Zacks.com featured highlights include: Vertex Pharmaceuticals, PerkinElmer, Stanley Black & Decker, 3M and Arthur J. Gallagher & Co

Zacks.com featured highlights include: Vertex Pharmaceuticals, PerkinElmer, Stanley Black & Decker, 3M and Arthur J. Gallagher & Co...…